Insights

Strategic Partnerships Leverage ongoing collaboration with General Graphene Corp and BARDA-era initiatives to position Hememics as a trusted provider of graphene-based sensing solutions for rapid diagnostics in healthcare, defense, and field operations.

Field-Ready Platform Highlight the rugged, portable reader and single-use biochips with 32 programmable sensors as a turnkey solution for on-site testing on farms, in ERs, or combat-support scenarios to shorten decision cycles.

Funding Momentum Capitalize on recent Seed 2 financing to unlock expansion in sales and marketing, channel development, and pilot programs with key healthcare, agritech, and emergency-response customers.

Rapid Diagnostics Value Position Bluetooth-enabled rapid antigen and antibody capabilities as a differentiator for quick on-site triage, disease surveillance, and outbreak response in hospital systems and field units.

Scale & Capacity Emphasize strong production collaboration with graphene biosensors and demonstrated high-volume manufacturing potential to support enterprise-scale deployments and recurring revenue from consumables.

Similar companies to Hememics Biotechnologies, Inc.

Hememics Biotechnologies, Inc. Tech Stack

Hememics Biotechnologies, Inc. uses 8 technology products and services including Amazon Web Services, Wix, WordPress, and more. Explore Hememics Biotechnologies, Inc.'s tech stack below.

Media & News

Hememics Biotechnologies, Inc.'s Email Address Formats

Hememics Biotechnologies, Inc. uses at least 2 email formats:
Hememics Biotechnologies, Inc. Email FormatsExamplePercentage
FLast@hememics.comJDoe@hememics.com
88%
First@hememics.comJohn@hememics.com
12%

Frequently Asked Questions

What is Hememics Biotechnologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s official website is hememics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Hememics Biotechnologies, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Hememics Biotechnologies, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Hememics Biotechnologies, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Hememics Biotechnologies, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Hememics Biotechnologies, Inc. has approximately 13 employees across 2 continents, including North America and Europe. Key team members include Chief Financial Officer: R. L., President: D. H. H. and Biotechnology Research Scientist: K. D. Explore Hememics Biotechnologies, Inc.'s employee directory with LeadIQ.

What industry does Hememics Biotechnologies, Inc. belong to?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc. operates in the Biotechnology Research industry.

What technology does Hememics Biotechnologies, Inc. use?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s tech stack includes Amazon Web Services, Wix, WordPress, Wix eCommerce, Google Workspace, Google Cloud, Sentry and Modernizr.

What is Hememics Biotechnologies, Inc.'s email format?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s email format typically follows the pattern of FLast@hememics.com. Find more Hememics Biotechnologies, Inc. email formats with LeadIQ.

How much funding has Hememics Biotechnologies, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, Hememics Biotechnologies, Inc. has raised $5.4M in funding. The last funding round occurred on Mar 19, 2025 for $250K.

When was Hememics Biotechnologies, Inc. founded?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc. was founded in 2007.
Hememics Biotechnologies, Inc. logo

Hememics Biotechnologies, Inc.

Biotechnology ResearchMaryland, United States11-50 Employees

Hememics Biotechnologies, Inc. is a biotechnology research company based in Gaithersburg, Maryland. It develops portable diagnostic platforms that combine graphene-based sensors with disposable biochips to deliver lab-quality results in settings such as farms, emergency rooms, and field environments, with results available in minutes. The company targets users who require rapid, on-site testing and decision-making capabilities, offering a handheld reader and programmable sensors that can detect molecular, antigen, and antibody targets, thereby simplifying testing workflows. Hememics positions itself within the biotechnology and rapid diagnostics space by providing a rugged, low-cost, end-to-end testing solution that brings laboratory-level capabilities to non-traditional lab environments. In recent developments, the company announced a partnership with General Graphene Corp., reflecting ongoing collaboration to manufacture graphene biosensors. Established in the United States, Hememics emphasizes its focus on rapid diagnostic tools and point-of-care applications through its technology platform. }

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $5.4M

    Hememics Biotechnologies, Inc. has raised a total of $5.4M of funding over 4 rounds. Their latest funding round was raised on Mar 19, 2025 in the amount of $250K as a Venture Round.

  • $1M - $10M

    Hememics Biotechnologies, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.